These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 9618289)
1. Plasma heparin-binding EGF-like growth factor levels in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. Yamada A; Kawata S; Tamura S; Kiso S; Higashiyama S; Umeshita K; Sakon M; Taniguchi N; Monden M; Matsuzawa Y Biochem Biophys Res Commun; 1998 May; 246(3):783-7. PubMed ID: 9618289 [TBL] [Abstract][Full Text] [Related]
2. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy. Kiso S; Kawata S; Tamura S; Higashiyama S; Ito N; Tsushima H; Taniguchi N; Matsuzawa Y Hepatology; 1995 Nov; 22(5):1584-90. PubMed ID: 7590679 [TBL] [Abstract][Full Text] [Related]
3. Serum levels of transforming growth factor-alpha in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. Tomiya T; Fujiwara K Hepatology; 1993 Aug; 18(2):304-8. PubMed ID: 8340059 [TBL] [Abstract][Full Text] [Related]
4. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer. Tomiya T; Hayashi S; Yanase M; Umeda N; Tani M; Yamada S; Masaki N; Ogata I; Fujiwara K Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-14-S6-17. PubMed ID: 9151911 [TBL] [Abstract][Full Text] [Related]
5. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome. Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193 [TBL] [Abstract][Full Text] [Related]
6. Heparin-binding EGF-like growth factor is a potent mitogen for rat hepatocytes. Ito N; Kawata S; Tamura S; Kiso S; Tsushima H; Damm D; Abraham JA; Higashiyama S; Taniguchi N; Matsuzawa Y Biochem Biophys Res Commun; 1994 Jan; 198(1):25-31. PubMed ID: 8292028 [TBL] [Abstract][Full Text] [Related]
17. Changes in serum levels of growth factors in healthy individuals after living related liver donation. Efimova EA; Glanemann M; Nussler AK; Schumacher G; Settmacher U; Jonas S; Nussler N; Neuhaus P Transplant Proc; 2005 Mar; 37(2):1074-5. PubMed ID: 15848626 [TBL] [Abstract][Full Text] [Related]
18. In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF. Khai NC; Takahashi T; Ushikoshi H; Nagano S; Yuge K; Esaki M; Kawai T; Goto K; Murofushi Y; Fujiwara T; Fujiwara H; Kosai K J Hepatol; 2006 Jun; 44(6):1046-54. PubMed ID: 16466829 [TBL] [Abstract][Full Text] [Related]
19. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons. Iwakura Y; Piao YS; Mizuno M; Takei N; Kakita A; Takahashi H; Nawa H J Neurochem; 2005 May; 93(4):974-83. PubMed ID: 15857400 [TBL] [Abstract][Full Text] [Related]
20. Assessment of HB-EGF levels in peritoneal fluid and serum of ovarian cancer patients using ELISA. Hikita S; Yotsumoto F; Fukami T; Horiuchi S; Sanui A; Miyata K; Nam SO; Tsujioka H; Ueda T; Shirota K; Yoshizato T; Maeda K; Ishikawa T; Okuno Y; Kuroki M; Mekada E; Miyamoto S Anticancer Res; 2011 Jul; 31(7):2553-9. PubMed ID: 21873174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]